These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 15228551

  • 41. Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-beta-lactamase-producing Escherichia coli isolates.
    Sorlozano A, Gutierrez J, Jimenez A, de Dios Luna J, Martínez JL.
    J Clin Microbiol; 2007 Aug; 45(8):2740-2. PubMed ID: 17567787
    [Abstract] [Full Text] [Related]

  • 42. [Investigating the fluoroquinolone molecular resistant mechanism of Stenotrophomonas maltophilia].
    Tao CM, Lü XJ, Li P.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):266-9. PubMed ID: 16608091
    [Abstract] [Full Text] [Related]

  • 43. Molecular characterization and typing of enrofloxacin-resistant clinical isolates of Mycoplasma gallisepticum.
    Lysnyansky I, Gerchman I, Perk S, Levisohn S.
    Avian Dis; 2008 Dec; 52(4):685-9. PubMed ID: 19166064
    [Abstract] [Full Text] [Related]

  • 44. An unusually high level of quinolone resistance associated with type II topoisomerase mutations in quinolone resistance-determining regions of Aeromonas caviae isolated from diarrhoeal patients.
    Sinha S, Chattopadhyay S, Bhattacharya SK, Nair GB, Ramamurthy T.
    Res Microbiol; 2004 Dec; 155(10):827-9. PubMed ID: 15567276
    [Abstract] [Full Text] [Related]

  • 45. Fluoroquinolone-resistant Brucella melitensis mutants obtained in vitro.
    Lázaro FG, Rodríguez-Tarazona RE, García-Rodríguez JA, Muñoz-Bellido JL.
    Int J Antimicrob Agents; 2009 Sep; 34(3):252-4. PubMed ID: 19243922
    [Abstract] [Full Text] [Related]

  • 46. DNA gyrase and topoisomerase IV mutations in an in vitro fluoroquinolone-resistant Coxiella burnetii strain.
    Vranakis I, Sandalakis V, Chochlakis D, Tselentis Y, Psaroulaki A.
    Microb Drug Resist; 2010 Jun; 16(2):111-7. PubMed ID: 20438350
    [Abstract] [Full Text] [Related]

  • 47. Type II topoisomerase mutations in clinical isolates of Enterobacter cloacae and other enterobacterial species harbouring the qnrA gene.
    Lascols C, Robert J, Cattoir V, Bébéar C, Cavallo JD, Podglajen I, Ploy MC, Bonnet R, Soussy CJ, Cambau E.
    Int J Antimicrob Agents; 2007 Apr; 29(4):402-9. PubMed ID: 17254753
    [Abstract] [Full Text] [Related]

  • 48. Rapid detection of a point mutation in the parC gene associated with decreased susceptibility to fluoroquinolones in Mycoplasma bovis.
    Lysnyansky I, Mikula I, Gerchman I, Levisohn S.
    Antimicrob Agents Chemother; 2009 Nov; 53(11):4911-4. PubMed ID: 19721062
    [Abstract] [Full Text] [Related]

  • 49. Antimicrobial susceptibility and molecular characterization of avian pathogenic Escherichia coli isolates.
    Zhao S, Maurer JJ, Hubert S, De Villena JF, McDermott PF, Meng J, Ayers S, English L, White DG.
    Vet Microbiol; 2005 May 20; 107(3-4):215-24. PubMed ID: 15863280
    [Abstract] [Full Text] [Related]

  • 50. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.
    Saito R, Sato K, Kumita W, Inami N, Nishiyama H, Okamura N, Moriya K, Koike K.
    J Antimicrob Chemother; 2006 Sep 20; 58(3):673-7. PubMed ID: 16870650
    [Abstract] [Full Text] [Related]

  • 51. Comparison of Mismatch Amplification Mutation Assay PCR and PCR-Restriction Fragment Length Polymorphism for Detection of Major Mutations in gyrA and parC of Escherichia coli Associated with Fluoroquinolone Resistance.
    Jazeela K, Chakraborty G, Shetty SS, Rohit A, Karunasagar I, Vijaya Kumar D.
    Microb Drug Resist; 2019 Sep 20; 25(1):23-31. PubMed ID: 30036132
    [Abstract] [Full Text] [Related]

  • 52. Antimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993-2002: continuous increasing of ciprofloxacin-resistant isolates.
    Tanaka M, Nakayama H, Notomi T, Irie S, Tsunoda Y, Okadome A, Saika T, Kobayashi I.
    Int J Antimicrob Agents; 2004 Sep 20; 24 Suppl 1():S15-22. PubMed ID: 15364300
    [Abstract] [Full Text] [Related]

  • 53. Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China.
    Pu XY, Pan JC, Wang HQ, Zhang W, Huang ZC, Gu YM.
    J Antimicrob Chemother; 2009 May 20; 63(5):917-20. PubMed ID: 19297378
    [Abstract] [Full Text] [Related]

  • 54. Molecular characterization of enrofloxacin resistant Actinobacillus pleuropneumoniae isolates.
    Wang YC, Chan JP, Yeh KS, Chang CC, Hsuan SL, Hsieh YM, Chang YC, Lai TC, Lin WH, Chen TH.
    Vet Microbiol; 2010 May 19; 142(3-4):309-12. PubMed ID: 19913366
    [Abstract] [Full Text] [Related]

  • 55. Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan.
    Kikuchi M, Ito S, Yasuda M, Tsuchiya T, Hatazaki K, Takanashi M, Ezaki T, Deguchi T.
    J Antimicrob Chemother; 2014 Sep 19; 69(9):2376-82. PubMed ID: 24894419
    [Abstract] [Full Text] [Related]

  • 56. Analysis of topoisomerase mutations in fluoroquinolone-resistant and -susceptible Campylobacter jejuni strains isolated in Senegal.
    Kinana AD, Cardinale E, Bahsoun I, Tall F, Sire JM, Garin B, Boye CS, Dromigny JA, Perrier-Gros-Claude JD.
    Int J Antimicrob Agents; 2007 Apr 19; 29(4):397-401. PubMed ID: 17224260
    [Abstract] [Full Text] [Related]

  • 57. The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations.
    Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Rice CL, Doern GV.
    Clin Infect Dis; 2005 Jan 15; 40(2):225-35. PubMed ID: 15655739
    [Abstract] [Full Text] [Related]

  • 58. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens.
    Chenia HY, Pillay B, Pillay D.
    J Antimicrob Chemother; 2006 Dec 15; 58(6):1274-8. PubMed ID: 17040923
    [Abstract] [Full Text] [Related]

  • 59. High-level resistance to fluoroquinolones linked to mutations in gyrA, parC, and parE in Salmonella enterica serovar Schwarzengrund isolates from humans in Taiwan.
    Baucheron S, Chaslus-Dancla E, Cloeckaert A, Chiu CH, Butaye P.
    Antimicrob Agents Chemother; 2005 Feb 15; 49(2):862-3. PubMed ID: 15673791
    [No Abstract] [Full Text] [Related]

  • 60. Fluoroquinolone resistance mechanism of clinical isolates and selected mutants of Pasteurella multocida from bovine respiratory disease in China.
    Kong LC, Gao D, Gao YH, Liu SM, Ma HX.
    J Vet Med Sci; 2014 Dec 15; 76(12):1655-7. PubMed ID: 25649952
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.